Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis

The detection of EGFR mutations in plasma or serum is a noninvasive method to confirm EGFR mutation status in patients with NSCLC. However, more work is necessary to identify which method can raise the sensitivity of EGFR mutation detection.